Adage Capital Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56M Buy
235,892
+13,092
+6% +$2.72M 0.08% 254
2026
Q1
$47.1M Buy
222,800
+207,151
+1,324% +$44.6M 0.07% 262
2025
Q4
$3.22M Buy
+15,649
New +$2.95M ﹤0.01% 805
2025
Q3
Sell
-218,600
Closed -$36.7M 897
2025
Q2
$36.7M Buy
218,600
+155,805
+248% +$23.1M 0.06% 303
2025
Q1
$8.65M Sell
62,795
-163,305
-72% -$20.8M 0.02% 614
2024
Q4
$26.7M Sell
226,100
-3,800
-2% -$444K 0.05% 361
2024
Q3
$25.4M Sell
229,900
-3,700
-2% -$387K 0.04% 393
2024
Q2
$23M Buy
+233,600
New +$23.8M 0.04% 394
2023
Q2
Sell
-258,000
Closed -$19.5M 877
2023
Q1
$19.5M Sell
258,000
-8,600
-3% -$649K 0.04% 416
2022
Q4
$20.5M Sell
266,600
-11,000
-4% -$836K 0.05% 419
2022
Q3
$18.5M Sell
277,600
-6,100
-2% -$387K 0.05% 430
2022
Q2
$14.8M Sell
283,700
-5,600
-2% -$318K 0.03% 552
2022
Q1
$16.4M Buy
289,300
+69,000
+31% +$3.7M 0.03% 554
2021
Q4
$11.3M Buy
220,300
+5,500
+3% +$270K 0.02% 662
2021
Q3
$10.6M Buy
214,800
+65,500
+44% +$3.55M 0.02% 673
2021
Q2
$8.52M Sell
149,300
-177,600
-54% -$10.4M 0.02% 736
2021
Q1
$19.9M Buy
326,900
+6,800
+2% +$375K 0.04% 457
2020
Q4
$17.1M Buy
320,100
+1,500
+0.5% +$77.8K 0.04% 459
2020
Q3
$15M Sell
318,600
-10,700
-3% -$549K 0.04% 444
2020
Q2
$17.2M Sell
329,300
-6,000
-2% -$309K 0.04% 424
2020
Q1
$16.1M Buy
335,300
+242,900
+263% +$12.6M 0.05% 370
2019
Q4
$4.67M Sell
92,400
-266,200
-74% -$13.7M 0.01% 617
2019
Q3
$16.9M Sell
358,600
-3,300
-0.9% -$151K 0.04% 407
2019
Q2
$17M Sell
361,900
-4,500
-1% -$208K 0.04% 398
2019
Q1
$17.6M Buy
366,400
+69,000
+23% +$3.46M 0.04% 411
2018
Q4
$13.3M Sell
297,400
-102,000
-26% -$5.32M 0.04% 438
2018
Q3
$21.6M Buy
399,400
+226,500
+131% +$11.6M 0.05% 380
2018
Q2
$8.44M Sell
172,900
-139,700
-45% -$7.92M 0.02% 587
2018
Q1
$19.6M Buy
312,600
+263,000
+530% +$18M 0.05% 396
2017
Q4
$3.04M Sell
49,600
-248,600
-83% -$15.4M 0.01% 650
2017
Q3
$20M Sell
298,200
-154,700
-34% -$10.9M 0.05% 418
2017
Q2
$35.3M Sell
452,900
-6,900
-2% -$521K 0.09% 303
2017
Q1
$37.5M Buy
459,800
+900
+0.2% +$70.8K 0.09% 274
2016
Q4
$33M Sell
458,900
-6,300
-1% -$455K 0.09% 277
2016
Q3
$36.1M Sell
465,200
-27,100
-6% -$2.19M 0.1% 271
2016
Q2
$38.4M Buy
492,300
+5,500
+1% +$438K 0.1% 235
2016
Q1
$39.9M Sell
486,800
-109,100
-18% -$8.87M 0.11% 225
2015
Q4
$53.2M Buy
595,900
+98,700
+20% +$8.38M 0.14% 189
2015
Q3
$38.2M Buy
497,200
+35,900
+8% +$3M 0.11% 246
2015
Q2
$38.6M Sell
461,300
-48,000
-9% -$4.24M 0.1% 265
2015
Q1
$46M Buy
509,300
+10,000
+2% +$861K 0.11% 240
2014
Q4
$40.3M Sell
499,300
-13,000
-3% -$1.03M 0.1% 267
2014
Q3
$38.4M Buy
512,300
+192,500
+60% +$14M 0.09% 264
2014
Q2
$21.9M Sell
319,800
-648,200
-67% -$44.1M 0.06% 376
2014
Q1
$67.7M Sell
968,000
-308,800
-24% -$21.5M 0.19% 163
2013
Q4
$85.3M Buy
1,276,800
+60,000
+5% +$3.67M 0.23% 130
2013
Q3
$63.5M Hold
1,216,800
0.18% 157
2013
Q2
$57.4M Buy
+1,216,800
New +$55.6M 0.18% 163

Other funds holding CAH

Adage Capital Partners's CAH Position: Q2 2026 in Review

Adage Capital Partners increased its Cardinal Health (CAH) stake by 5.9% in Q2 2026, buying an estimated $2.72M and bringing the position to 235,892 shares worth $56M. The position accounts for 0.08% of the portfolio, ranked #254.

Adage Capital Partners first reported a position in CAH in Q2 2013 and has held it in 48 quarters since. The position peaked at $85.3M in Q4 2013. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Adage Capital Partners held 235,892 shares of Cardinal Health worth $56M as of Q2 2026.
  • Adage Capital Partners bought 13,092 Cardinal Health shares in Q2 2026, an estimated $2.72M.
  • Cardinal Health made up 0.08% of Adage Capital Partners's portfolio in Q2 2026, its #254 holding.
  • Adage Capital Partners first reported a position in Cardinal Health in Q2 2013 and has held it in 48 quarters since.
  • Adage Capital Partners's Cardinal Health position peaked at $85.3M in Q4 2013.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.